Leighton was Senior Vice President of Administration, Planning and Science
Policy at Merck & Co., Inc. for nearly three decades. He passed away
on June 1st of 1993. Dr. Leighton joined Merck & Co., in 1965, as
a Harvard MD graduate who was interested in employing his medical background
to help a far larger number of patients than that possible in medical
practice. He distinguished himself through his leadership and vision,
and his gift for galvanizing and harmonizing scientists, company management,
and government officials behind a common goal - delivering breakthrough
medicines and vaccines to the people who need them around the world. Charles'
longstanding and exceptional contributions have helped make Merck the
company it is today -- a company with an unprecedented track record of
innovation - discovering and developing more new medicines than any other
research organization in the world.